CA2504076C - Reseau elastomere degradable - Google Patents
Reseau elastomere degradable Download PDFInfo
- Publication number
- CA2504076C CA2504076C CA 2504076 CA2504076A CA2504076C CA 2504076 C CA2504076 C CA 2504076C CA 2504076 CA2504076 CA 2504076 CA 2504076 A CA2504076 A CA 2504076A CA 2504076 C CA2504076 C CA 2504076C
- Authority
- CA
- Canada
- Prior art keywords
- elastomer
- polymer
- poly
- cross
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2504076 CA2504076C (fr) | 2005-04-14 | 2005-04-14 | Reseau elastomere degradable |
US11/403,203 US20060233857A1 (en) | 2005-04-14 | 2006-04-13 | Degradable elastomeric network |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2504076 CA2504076C (fr) | 2005-04-14 | 2005-04-14 | Reseau elastomere degradable |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2504076A1 CA2504076A1 (fr) | 2006-10-14 |
CA2504076C true CA2504076C (fr) | 2014-12-09 |
Family
ID=37101432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2504076 Expired - Fee Related CA2504076C (fr) | 2005-04-14 | 2005-04-14 | Reseau elastomere degradable |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2504076C (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113181157B (zh) * | 2021-05-24 | 2023-04-07 | 万华化学集团股份有限公司 | 一种维生素a乙酸酯微囊的制备方法 |
CN114306724B (zh) * | 2021-12-30 | 2022-11-11 | 上海汇禾医疗科技有限公司 | 一种可缓释药物的栓塞微球及其制备方法 |
-
2005
- 2005-04-14 CA CA 2504076 patent/CA2504076C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2504076A1 (fr) | 2006-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060233857A1 (en) | Degradable elastomeric network | |
Agarwal et al. | Injectable implants for the sustained release of protein and peptide drugs | |
Buwalda et al. | Hydrogels in a historical perspective: From simple networks to smart materials | |
Kempe et al. | In situ forming implants—an attractive formulation principle for parenteral depot formulations | |
Hatefi et al. | Biodegradable injectable in situ forming drug delivery systems | |
Yu et al. | Injectable hydrogels as unique biomedical materials | |
Bos et al. | In situ crosslinked biodegradable hydrogels loaded with IL-2 are effective tools for local IL-2 therapy | |
Tamada et al. | The development of polyanhydrides for drug delivery applications | |
Ravi Kumar et al. | Polymeric controlled drug-delivery systems: perspective issues and opportunities | |
US6984393B2 (en) | Biodegradable elastomer and method of preparing same | |
US6497903B1 (en) | Hydrolysable hydrogels for controlled release | |
EP0863933B1 (fr) | Nouveaux hydrogels a base de copolymeres trisequences, leur preparation et leur application | |
Ferreira et al. | Photocrosslinkable polymers for biomedical applications | |
Bos et al. | Tissue reactions of in situ formed dextran hydrogels crosslinked by stereocomplex formation after subcutaneous implantation in rats | |
Sinha et al. | Bioabsorbable polymers for implantable therapeutic systems | |
US20100255098A1 (en) | Stereocomplex hydrogels | |
EP1891941A1 (fr) | Formulations des gel aqueuses comprenant des microsphères | |
Loh et al. | Biodegradable thermogelling polymers | |
JP2011526288A (ja) | エキセナチド及び他のポリペプチド類の持続的送達 | |
Amsden | Novel biodegradable polymers for local growth factor delivery | |
Ghosh | Recent research and development in synthetic polymer-based drug delivery systems | |
AL et al. | Biodegradable polymers: Which, when and why? | |
Jerbic | Biodegradable synthetic polymers and their application in advanced drug delivery systems (DDS) | |
US20170035895A1 (en) | Dehydrated hydrogel inclusion complex | |
CA2504076C (fr) | Reseau elastomere degradable |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20200831 |